These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30270253)

  • 21. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
    Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
    Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR manifestations of uterine polypoid adenomyoma.
    Takeuchi M; Matsuzaki K; Harada M
    Abdom Imaging; 2015 Mar; 40(3):480-7. PubMed ID: 25516215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
    Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
    Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The utility of MRI for the preoperative differential diagnosis of uterine sarcoma and leiomyoma: a single-center study.
    Yazawa H; Yazawa R; Anjo K; Inazuki A; Kikuta M
    Fukushima J Med Sci; 2024 Oct; 70(4):211-218. PubMed ID: 39370272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation.
    Liu J; Wei J; Keserci B; Zhang J; Yang X; Wang X
    Int J Gynaecol Obstet; 2016 Jan; 132(1):100-2. PubMed ID: 26475075
    [No Abstract]   [Full Text] [Related]  

  • 26. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging analysis of heterogeneous leiomyomas of the uterus.
    Ha HK; Jee MK; Lee HJ; Choe BY; Park JS; Lee JM; Nam-Koong SE
    Front Biosci; 1997 Apr; 2():f4-12. PubMed ID: 9159188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
    Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
    Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI screening for uterine leiomyosarcoma.
    Tong A; Kang SK; Huang C; Huang K; Slevin A; Hindman N
    J Magn Reson Imaging; 2019 Jun; 49(7):e282-e294. PubMed ID: 30637854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR imaging findings of uterine pyomyoma: radiologic-pathologic correlation.
    Ono H; Kanematsu M; Kato H; Toyoki H; Hayasaki Y; Furui T; Morishige K; Hatano Y
    Abdom Imaging; 2014 Aug; 39(4):797-801. PubMed ID: 24615512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
    Kim TH; Kim JW; Kim SY; Kim SH; Cho JY
    J Gynecol Oncol; 2018 May; 29(3):e26. PubMed ID: 29400019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
    Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
    Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR imaging of hemorrhagic conditions of the head and neck.
    Grossman RI; Gomori JM; Goldberg HI; Hackney DB; Atlas SW; Kemp SS; Zimmerman RA; Bilaniuk LT
    Radiographics; 1988 May; 8(3):441-54. PubMed ID: 3380990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
    Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.
    Tamura R; Kashima K; Asatani M; Nishino K; Nishikawa N; Sekine M; Serikawa T; Enomoto T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1042-7. PubMed ID: 24927248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudolesions related to uterine contraction: characterization with multiphase-multisection T2-weighted MR imaging.
    Masui T; Katayama M; Kobayashi S; Shimizu S; Nozaki A; Sakahara H
    Radiology; 2003 May; 227(2):345-52. PubMed ID: 12618545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging findings of ovarian torsion correlate with pathological hemorrhagic infarction.
    Moribata Y; Kido A; Yamaoka T; Mikami Y; Himoto Y; Kataoka M; Fujimoto K; Konishi I; Togashi K
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1433-9. PubMed ID: 25976614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Submucosal uterine leiomyomas: diagnosis of prolapse into the cervix and vagina based on MR imaging.
    Panageas E; Kier R; McCauley TR; McCarthy S
    AJR Am J Roentgenol; 1992 Sep; 159(3):555-8. PubMed ID: 1503024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue.
    Oguchi O; Mori A; Kobayashi Y; Horiuchi A; Nikaido T; Fujii S
    J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):107-17. PubMed ID: 8556572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging is accurate to detect bleeding in the seminal vesicles in patients with hemospermia.
    Furuya S; Furuya R; Masumori N; Tsukamoto T; Nagaoka M
    Urology; 2008 Oct; 72(4):838-42. PubMed ID: 18692870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.